Pemetrexed Sandoz 500 mg Powder for concentrate for solution for infusion
Sponsors
Incyte Corp., Summit Therapeutics Inc.
Conditions
Metastatic nonsquamous or squamous non-small cell lung cancerPatients With EGFR-mutant Locally Advanced or Metastatic Non-squamous NSCLC Who Have Failed to EGFR-TKI Treatment
Phase 3
A Randomized, Double-blind, Multi-center, Phase III Study of AK112 or Placebo Combined With Pemetrexed and Carboplatin in Patients With EGFR-mutant Locally Advanced or Metastatic Non-squamous NSCLC Who Have Failed to EGFR-TKI Treatment (HARMONi)
Active, not recruitingCTIS2023-504434-22-00
Start: 2023-10-03Target: 45Updated: 2025-12-16
A Randomized, Double Blind, Phase 3 Study of Platinum-Based Chemotherapy With or Without INCMGA00012 in First-Line Metastatic Squamous and Nonsquamous Non–Small Cell Lung Cancer (POD1UM-304)
Active, not recruitingCTIS2022-501987-16-00
Start: 2020-10-02Target: 14Updated: 2025-08-05